Operating Company Business Services

eMolecules

San Diego, California, United States

Chemical compound search-and-fulfillment platform for early drug discovery, providing scientists access to large searchable chemical space plus integrated compound procurement, reformatting/storage and inventory management services (including synthesis/fulfillment capabilities).

Focus Areas
Chemical compound search and fulfillment, Compound procurement, Compound reformatting

Tracked deals

3

3 tracked deals across 2022-2024.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Addon

2 addon · 1 buyout

eMolecules Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for eMolecules. 1 2022 1 2023 1 2024

Supporting Data

Recent Transactions

  • eMolecules Acquires Synple Chem AG
    September 24, 2024
    Buyer
    eMolecules, Inc.
    Target
    Synple Chem AG
    Industry
    Biotechnology
    Location
    Zurich, Switzerland
    Type
    Addon

    eMolecules, a San Diego-based provider of a chemical compound search-and-fulfillment platform and a portfolio company of Avista Healthcare Partners, has acquired Synple Chem AG, an automated chemical synthesis systems and services provider headquartered near Zurich, Switzerland. The acquisition adds Synple's automation technology and a virtual compound library of more than 7 trillion tractable compounds to eMolecules' existing offering, expanding its capabilities as a one-stop shop for compound procurement, management and automation for drug discovery customers.

  • eMolecules Acquires Specs Compound Handling B.V.
    May 25, 2023
    Buyer
    eMolecules, Inc., Avista Capital Partners
    Target
    Specs Compound Handling B.V.
    Industry
    Healthcare Services
    Location
    South Holland, Netherlands
    Type
    Buyout

    eMolecules, a San Diego–based chemical compound search-and-fulfillment platform, has acquired Specs Compound Handling B.V., a Netherlands-headquartered provider of compound reformatting, repository and management services. The acquisition expands eMolecules' global compound reformatting and inventory management footprint—adding European and US facilities—and is supported by eMolecules' existing investors, including Avista Capital Partners.

  • eMolecules Acquires Frontier Scientific Inc. and Frontier Agricultural Sciences Inc.
    September 7, 2022
    Buyer
    eMolecules, Inc., Avista Capital Partners
    Target
    Frontier Scientific Inc., Frontier Agricultural Sciences Inc.
    Industry
    Pharmaceuticals
    Location
    Delaware, United States
    Type
    Addon

    eMolecules, a PE-backed provider of a chemistry search-and-fulfillment platform, has acquired Frontier Scientific Inc. (FSI) and Frontier Agricultural Sciences Inc. (FAS). The acquisitions expand eMolecules' capabilities in compound/sample management, analytical and procurement services and provide an entry into agricultural chemistry/entomology research markets.

Related Acquisition Pages

Biotechnology Buyers & Acquisitions 1 tracked deal by eMolecules. Healthcare Services Buyers & Acquisitions 1 tracked deal by eMolecules. Pharmaceuticals Buyers & Acquisitions 1 tracked deal by eMolecules. Acquisitions in Delaware 1 tracked deal by eMolecules.

Related articles

Selling a company? Get in front of buyers like eMolecules

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →